Compounds > 9,10-phenanthrenequinone
Page last updated: 2024-08-17

9,10-phenanthrenequinone and indomethacin

9,10-phenanthrenequinone has been researched along with indomethacin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Fujii, Y; Hayaishi, O; Hayashi, H; Watanabe, K1
Byrns, MC; Penning, TM; Steckelbroeck, S1

Other Studies

3 other study(ies) available for 9,10-phenanthrenequinone and indomethacin

ArticleYear
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
Enzymatic formation of prostaglandin F2 alpha in human brain.
    Neurochemical research, 1990, Volume: 15, Issue:4

    Topics: Amino Acids; Binding Sites; Brain; Catalysis; Dinoprost; Dinoprostone; Ethacrynic Acid; Humans; Hydrogen-Ion Concentration; Hydroxyprostaglandin Dehydrogenases; Indomethacin; Isoelectric Point; Molecular Weight; NADP; Phenanthrenes; Prostaglandins; Substrate Specificity; Triazines; Vitamin K

1990
An indomethacin analogue, N-(4-chlorobenzoyl)-melatonin, is a selective inhibitor of aldo-keto reductase 1C3 (type 2 3alpha-HSD, type 5 17beta-HSD, and prostaglandin F synthase), a potential target for the treatment of hormone dependent and hormone indepe
    Biochemical pharmacology, 2008, Jan-15, Volume: 75, Issue:2

    Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Catalysis; Dihydrotestosterone; Enzyme Inhibitors; Humans; Hydroxyprostaglandin Dehydrogenases; Indoles; Indomethacin; Melatonin; Neoplasms, Hormone-Dependent; Oxidation-Reduction; Phenanthrenes

2008